Bracco Issues Voluntary Recall of Isovue Pre-filled Syringes

Bracco Diagnostics Inc. (BDI) has voluntarily initiated a Class I recall of nine lots of Isovue® (iopamidol injection) Pre-Filled Power Injector Syringes (Isovue PFS, to be used in combination with Stellant® CT Injection Systems) due to the presence of visible particles in syringes observed at the end of standard stability studies on retained samples, according to the U.S. Food and Drug Administration (FDA).The FDA has full knowledge of the voluntary recall and is helping spread the word about it to providers and patients. There have been no complaints or reports of patient harm arising from use of these nine recalled lots of Isovue. However, the FDA warned that the injections with the visible particle matter do have the potential to cause “adverse health consequences,” and should definitely not be used. Isovue is used for angiography throughout the cardiovascular system, and arterial injection of Isovue (for cerebral angiography) with particulate matter formation could cause a stroke. Bracco sold the lots to wholesalers and distributors nationwide between January 21, 2010 and May 9, 2012. The company has sent letters about the recall to its wholesalers, distributors and customers, and arranged for them to return any unused isovue injections that were part of the recall. Diagnostic imaging providers should check their stocks of Isovue PFS and “immediately quarantine” any injections that were part of the following lots:
Isovue® - 370NDCDescriptionLot NumberExpiry Date
Isovue® - 370 FLS20270-1316-6610 X 75 mL Power Injector Syringes, Stellant9L4074612/31/2012
Isovue® - 370 FLS20270-1316-6710 X 100 mL Power Injector Syringes, Stellant0A4370501/31/2013
Isovue® - 370 FLS20270-1316-6710 X 100 mL Power Injector Syringes, Stellant0C5750903/31/2013
Isovue® - 370 FLS20270-1316-6810 X 125 mL Power Injector Syringes, Stellant9K3779111/30/2012
Isovue® - 370 FLS20270-1316-6810 X 125 mL Power Injector Syringes, Stellant0C5752103/31/2013
Isovue® - 370 FLS20270-1316-6810 X 125 mL Power Injector Syringes, Stellant0E6291305/31/2013
Isovue® - 300NDCDescriptionLot NumberExpiry Date
Isovue® - 300 FLS20270-1315-6710 X 100 mL Power Injector Syringes, Stellant9K3457211/30/2012
Isovue® - 300 FLS20270-1315-6710 X 100 mL Power Injector Syringes, Stellant0A4328201/31/2013
Isovue® - 300 FLS20270-1315-6710 X 100 mL Power Injector Syringes, Stellant0C5628303/31/2013
To view pictures of the product labels on the FDA’s website, please click here. If you have an affected product in stock, Bracco asks that you contact Stericycle, its contractor for handling the recall, at 1-866-201-9133 to arrange for return of the product. Call center hours are Monday through Friday 8 a.m. to 5 p.m. Eastern Standard Time. Consumers with questions can also contact Stericyclen at that same number.
Lena Kauffman,

Contributor

Lena Kauffman is a contributing writer based in Ann Arbor, Michigan.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.